HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
Prevencio and Emory Winship Cancer Institute AI-driven HART CVE Test Data Predicts Risk of Adverse Cardiovascular Effects Associated with Prostate Cancer Therapy
Researchers and clinicians from Emory Winship Cancer Institute collaborated to test their prostate cancer population notes Prevencio.
Invizius Treats First Patients in First-In-Human Phase 1 Clinical Study of Lead Dialysis Product H-Guard ®
First patients treated with H-Guard at the National Institute for Health and Care Research Manchester Clinical Research Facility. MHRA approves continuation of Invizius's first-in-human clinical study following a prearranged two-patient safety and performance review. Study is investigating safety and tolerability of H-Guard®, a second generation complement regulator, to address serious immune system-driven complications of dialysis.
Dilon Technologies Announces the Beginning of Enrollment in its Pivotal Trial of the Next Generation MarginProbe™ 2 Used in Real-Time Margin Assessment
Dilon Technologies looks to continue building evidence around its MarginProbe™ platform that already has over 12 peer-reviewed publications demonstrating reduction in re-excision rates. "We remain committed to being a leader in women's healthcare by providing technology for patients that will improve their outcomes. MarginProbe™ is beginning to become an integral component of breast surgery for more surgeons across the United States each month," stated George Makhoul, CEO of Dilon Technologies.
Randomized Controlled Trial for the EkoSonic™ Endovascular System Commences
"Optimal treatment of PE is still poorly understood and there is a need for a coordinated institutional approach to this complex, life-threatening problem," said Kenneth Rosenfield, M.D., study co-lead principal investigator and section head, Vascular Medicine and Intervention, Division of Cardiology, Massachusetts General Hospital, Boston. "The lead investigators of the trial are pleased to collaborate with the PERT Consortium, which is committed to evidence-driven therapy and is proud to take part in the HI-PEITHO study, aiming to advance the care of patients with PE."
In a Usability Analysis of the ArthroFree Wireless Surgical Camera by Lazurite®, More than 90% of Respondents Agree the Absence of Cables Will Have...
Medical device and technology company Lazurite® announced that a new article just published in the Journal of Orthopaedic Experience & Innovation provides key support for the usability of the company’s ArthroFree® wireless surgical camera.
Surgical Innovation Associates Reports 1st US Patient Implanted in Pivotal IDE Study of DuraSorb Monofilament Mesh Use in Prosthetic Breast Reconstruction
The study will evaluate the safety and effectiveness of DuraSorb® for reinforcement in prosthetic breast reconstruction.
Growth in Use of Proton Therapy for Treating Wider Variety of Conditions | According to New Study Published in Red Journal Reveals Growth
Based on NAPT member survey data and other sources, “Temporal Evolution and Diagnostic Diversification of Patients Receiving Proton Therapy in the United States: A Ten-Year Trend Analysis (2012-21) from the National Association for Proton Therapy” largely debunks the misperception that proton therapy is used primarily as a treatment for prostate cancer.
BENEFIT-01 Study Now Published in Neuromodulation: A Glimpse into the Future of Spinal Cord Stimulation Programming
"BENEFIT-01 Study was the first in a series of studies that speaks to our commitment to advancing and sharing the science behind SCS. It’s exciting to see these learnings realized as patients experience the positive impact of RESONANCE™ stimulation with our Prospera™ SCS system," said Todd Langevin.
Sensorion Announces Approval to Initiate Lead Gene Therapy Candidate SENS-501 (OTOF-GT) into a Phase 1/2 Clinical Trial in some European Countries
Sensorion notes This gene therapy for patients suffering from otoferlin deficiency has been developed in the framework of RHU AUDINNOVE, a consortium composed of Sensorion with the Necker Enfants Malades Hospital, the Institut Pasteur, and the Fondation pour l’Audition. The project is partially financed by the French National Research Agency, through the “investing for the future” program (ref: ANR-18-RHUS-0007).
